In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $41.21, denoting a -1.44% change from the preceding trading day. ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE ...
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.analchem.4c05325. Additional data on the impact of flow rate ...
Citalopram exhibits immune-dependent anti-tumor effects by modulating C5aR1 + TAMs and CD8 + T cells
This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...
However, the contribution of additional SLC superfamily members to ferroptosis remains poorly understood. Here, we use a targeted CRISPR-Cas9 screen of the SLC superfamily to identify SLC25A1 as a ...
Southwest United Graduate School, Yunnan Key Laboratory of Cell Metabolism and Diseases, State Key Laboratory of Conservation and Utilization of Bio-resources in Yunnan Center for Life Sciences, ...
For most adults, depending on age, doctors will recommend a screening schedule that includes regular physical exams, body mass index (BMI), skin checks, cholesterol and blood pressure screening, eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback